Welcome to our dedicated page for Genesco SEC filings (Ticker: GCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genesco Inc. filings document formal disclosures for a Tennessee-based footwear retailer and brand operator. Recent Form 8-K reports cover quarterly and annual operating results, comparable sales by retail segment, GAAP and non-GAAP financial measures, and presentation materials furnished with earnings releases.
The company’s filings also record material corporate actions involving its credit agreement, including revolving credit facility terms, collateral, borrowing-base provisions, benchmark-rate changes, and covenant mechanics. Governance and compensation disclosures include executive finance and accounting transitions, principal financial and accounting officer designations, consulting arrangements, and the Genesco Inc. Short-Term Incentive Plan for eligible employees and named executive officers.
Genesco Inc. has adopted a new Short-Term Incentive Plan (STIP), replacing its Fourth Amended and Restated EVA Plan. The STIP will apply starting with the company’s 2027 fiscal year and covers eligible employees, including named executive officers.
The Compensation Committee will set annual financial, operational, and strategic performance goals for each business unit and the corporate unit, and establish a Target Award for each participant. Bonuses are paid in cash, generally based 75% on business unit or corporate results and 25% on those results adjusted by individual performance.
Declared bonuses can be reduced at the Committee’s discretion and are generally capped at three times a participant’s Target Award. Awards are subject to employment-eligibility conditions, performance standards, and potential reduction, forfeiture, or clawback under company policy or applicable law.
Ewoldsen Daniel E reported acquisition or exercise transactions in this Form 4 filing.
GENESCO INC Senior VP Daniel E. Ewoldsen received a grant of 7,681 shares of common stock on April 2, 2026. The shares were awarded at no cash cost to him as restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan. After this award, he directly holds 52,430 common shares.
GENESCO INC senior vice president and general counsel Scott E. Becker reported an equity compensation award on Common Stock. On April 2, 2026, he acquired 9,903 shares through a grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan at a stated price of $0.00 per share. After this award, he directly holds 67,158 shares of Genesco common stock.
VAUGHN MIMI ECKEL reported acquisition or exercise transactions in this Form 4 filing.
GENESCO INC reported that Board Chair, President & CEO Mimi Eckel Vaughn received a grant of 74,832 shares of Common Stock on April 2, 2026. The award is restricted stock granted under the Third Amended and Restated 2020 Equity Incentive Plan and carries no purchase price. Following this equity grant, Vaughn directly holds 450,328 shares of Genesco common stock.
Gray Andrew reported acquisition or exercise transactions in this Form 4 filing.
GENESCO INC Senior VP Andrew Gray received a grant of company stock. He was awarded 376 shares of common stock as restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan, increasing his direct holdings to 87,371 shares following the grant. This is a compensation-related equity award, not an open-market trade.
GENESCO INC Senior VP Daniel E. Ewoldsen reported a routine tax-related share disposition. On the vesting of restricted stock granted under the company’s 2020 Equity Incentive Plan, 1,527 shares of common stock were withheld at $28.39 per share to satisfy minimum tax withholding obligations, leaving him with 44,749 directly owned shares.
GENESCO INC Senior VP Andrew Gray reported a routine tax-related share disposition. On the vesting of restricted stock granted under the Third Amended and Restated 2020 Equity Incentive Plan, 2,141 shares of common stock were withheld to cover minimum tax withholding liability at an implied value of $28.39 per share.
After this tax-withholding event, Gray directly holds 86,995 shares of GENESCO common stock. This was not an open-market sale but an automatic share withholding tied to equity compensation vesting.
Genesco Inc. senior vice president and Chief Strategy & Digital Officer Parag Desai reported a routine tax-related share disposition. On the vesting of restricted stock granted under the company’s Third Amended and Restated 2020 Equity Incentive Plan, 2,188 common shares were withheld at $28.39 per share to cover minimum tax obligations. After this withholding, Desai directly owns 97,997 Genesco common shares, so the event reflects compensation and tax treatment rather than an open-market trade.
GENESCO INC senior vice president and general counsel Scott E. Becker reported a routine tax-related stock transaction. On April 2, 2026, 1,946 shares of common stock were withheld at $28.39 per share to cover minimum tax obligations upon vesting of restricted stock.
After this tax-withholding disposition, Becker directly holds 57,255 shares of Genesco common stock. The filing indicates the shares relate to restricted stock granted under the company’s Third Amended and Restated 2020 Equity Incentive Plan, and does not reflect an open-market sale.
GENESCO INC director and Board Chair, President & CEO Mimi Eckel Vaughn had 22,583 shares of Common Stock withheld on April 2, 2026 to satisfy minimum tax withholding obligations tied to the vesting of restricted stock under the company’s 2020 Equity Incentive Plan.
The shares were valued at $28.39 per share for this tax-withholding disposition. After this non-market transaction, she directly holds 375,496 shares of Genesco common stock, reflecting her continuing equity stake in the company following the restricted stock vesting.